Show Stocks and Investing Publications • Fri, November 11, 2022
Scott Fidel Maintained (AMED) at Hold with Decreased Target to $106 on, Nov 11th, 2022
l-maintained-amed-at-hold-with-decreased-target-to-106-on-nov-11th-2022.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIScott Fidel of Stephens & Co., Maintained "Amedisys, Inc." (AMED) at Hold with Decreased Target from $122 to $106 on, Nov 11th, 2022.
Scott has made no other calls on AMED in the last 4 months.
There are 9 other peers that have a rating on AMED. Out of the 9 peers that are also analyzing AMED, 2 agree with Scott's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $96 on, Tuesday, November 1st, 2022
- John Ransom of "Raymond James" Downgraded from Buy to Hold on, Thursday, October 27th, 2022
These are the ratings of the 7 analyists that currently disagree with Scott
- Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $139 on, Monday, October 31st, 2022
- David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $130 on, Friday, October 28th, 2022
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $145 on, Friday, October 28th, 2022
- Sarah James of "Barclays" Maintained at Buy with Decreased Target to $126 on, Friday, October 28th, 2022
- Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $165 on, Monday, October 24th, 2022
- Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $135 on, Monday, October 3rd, 2022
- Andrew Mok of "UBS" Downgraded from Hold to Strong Sell and Decreased Target to $95 on, Tuesday, August 2nd, 2022
Like: 👍